Open AccessMedical Care Expenditures for Genital Herpes in the United States
Author(s) -
Guoyu Tao,
William J. Kassler,
David B. Rein
Publication year - 2000
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/00007435-200001000-00007
Subject(s) - medicine , pharmacy , family medicine , public health , indirect costs , environmental health , demography , nursing , accounting , business , sociology
Approximately 45 million Americans have serologic evidence of HSV-2 infection and HSV-2 seroprevalence in the United States has increased 30% over the past two decades. Despite rapid increases in HSV-2 prevalence, the last estimate of the U.S. national direct medical cost for genital herpes (GH) was completed in 1985. The objective of this study is to assess the U.S. direct medical expenditures for GH and its complications to assist policy makers in allocating limited STD resources efficiently.